Global X Management Company’s Ionis Pharmaceuticals IONS Stock Holding History

Global X Management Company’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$111K	Buy	2,671 +233	+10%	+$10.3K	﹤0.01%	993
2018 Q1	$107K	Buy	2,438 +460	+23%	+$23.4K	﹤0.01%	963
2017 Q4	$99K	Buy	1,978 +485	+32%	+$26.6K	﹤0.01%	857
2017 Q3	$76K	Buy	1,493 +158	+12%	+$8.28K	﹤0.01%	889
2017 Q2	$68K	Buy	1,335 +429	+47%	+$20K	﹤0.01%	946
2017 Q1	$36K	Buy	906 +635	+234%	+$28.5K	﹤0.01%	959
2016 Q4	$13K	Buy	271 +9	+3%	+$356	﹤0.01%	1023
2016 Q3	$10K	Hold	262	–	–	﹤0.01%	1007
2016 Q2	$6K	Buy	+262	New	+$8.45K	﹤0.01%	916

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Global X Management Company's IONS Position: Q2 2018 in Review

Global X Management Company increased its Ionis Pharmaceuticals (IONS) stake by 9.6% in Q2 2018, buying an estimated $10.3K and bringing the position to 2,671 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Global X Management Company first reported a position in IONS in Q2 2016 and has held it in 9 quarters since. 308 funds tracked by Wall St. Rank hold IONS as of Q2 2018.

Global X Management Company held 2,671 shares of Ionis Pharmaceuticals worth $111K as of Q2 2018.
Global X Management Company bought 233 Ionis Pharmaceuticals shares in Q2 2018, an estimated $10.3K.
Ionis Pharmaceuticals made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #993 holding.
Global X Management Company first reported a position in Ionis Pharmaceuticals in Q2 2016 and has held it in 9 quarters since.
308 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.